Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you manage PSA progression while a patient is on Xofigo or Pluvicto?

5
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Corewell Health

The tl;drPSA is very much an imperfect tool for these patients. The data show that PSA may initially increase over multiple cycles before decreasing, though this is a minority of patients. Most patients whose PSA increases early have resistant disease, and you should investigate further with imaging...

Would you treat a male breast cancer patient with post-mastectomy radiotherapy for a single positive sentinel lymph node and a low Oncotype?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

In the setting of a mastectomy with a positive SLN and no ALND, I tend to extrapolate from AMAROS. While Z0011 had no mastectomy and AMAROS limited mastectomy patients, I am comfortable extrapolating axillary management to mastectomy setting.In this case, I would offer PMRT to chest wall and regiona...

Would you offer adjuvant chemotherapy or radiation to a resected MSS T3N0 high-rectal lesion with low anterior resection without pre-op therapy?

5
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic School of Medicine

For patients with T3N0 upper rectal cancer with no significant risk factors (R0, CRM clear, no EMVI) who undergo high quality TME surgery as suggested by an intact TME pathologic specimen, the 5-year risk of pelvic recurrence without the delivery of adjuvant radiotherapy is < 5%. I do not recommend ...

Should high risk prostate cancer patients be placed on more potent ADT (abiraterone or enzalutamide) in the upfront setting with definitive RT instead of the standard LHRH agonist?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · AdventHealth Cancer Institute

With STAMPEDE suggesting improvement with the addition of abiraterone in very high risk N0 patients, this is certainly becoming a consideration. Duke is completing a trial of concurrent abiraterone/STADT/definitive radiation for intermediate and lower high risk prostate cancer. Results forthcoming. ...

How do you approach liver SBRT in patients with hepatocellular carcinoma who aren't candidates for surgery or other interventional procedures when the overall liver volume is small making it difficult to achieve liver constraints?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Cincinnati College of Medicine

These are tough situations. I have used proton and photons for HCC. In the situation you described, I would generally favor IMPT due to improved low dose distribution and keeping the parenchyma not treated to a minimum while still giving an ablative dose more comfortably. Although the mean liver dos...

What neoadjuvant approach is best for an adenocarcinoma of the GE junction (arising in Barrett's) with a large hiatal hernia?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Moffitt Cancer Center

I haven't found any publication or clinical trial regarding this very incidental finding. However, I had the opportunity of discussing in tumor board a similar case. I suggested to consider surgical management of the hiatal hernia first, and shortly after recovering, proceed with chemotherapy and ra...

If a patient diagnosed with seminoma after orchiectomy has margin positive disease noted in the spermatic cord and no overt metastasis on imaging and normal tumor markers, how should this patient be staged?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Emory University School of Medicine

I believe that the staging would be pT3cN0M0S0 in this case. Margin-positive disease suggests continuous rather than discontinuous spermatic cord invasion. In case this was felt to be discontinuous, NCCN v1.2024 now has a note on staging such patients as pT3 (high-risk stage I) and not as M1 (stage ...

Do you prefer to treat patients prone (on a belly board) or supine when treating rectal cancers?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

If the goal is reducing small bowel dose, one should use a belly board and treat in prone position. There was a systematic review in the Green Journal regarding this. It's also beneficial when treating with IMRT, as seen in this publication.

How would you manage an epidural spinal metastasis causing cord compression from rhabdomyosarcoma?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

Leptomeningeal spread of rhabdomyosarcoma could result from the dissemination of tumor cells in the CSF by direct extension or by malignant cells growing along blood vessels or nerve sheaths. I would first get a total spine and a brain MRI to assess where there is gross disease present in other part...

Would you recommend adjuvant radiation for a large dedifferentiated anterior abdominal wall liposarcoma?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arkansas for Medical Sciences

When I have the opportunity to evaluate such a patient before treatment begins, I strongly favor pre-operative radiation with conventional fractionation and margins. If meeting the patient after surgery, it depends a great deal on how the closure was accomplished: reconstructed abdominal wall, prima...